IDEXX Laboratories

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems for veterinarians; and biological materials testing and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic, health-monitoring, and food safety testing products for livestock, poultry, and dairy; products that test water for certain microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.

Type
Public
HQ
Westbrook, US
Founded
1983
Size (employees)
7,365 (est)+9%
IDEXX Laboratories was founded in 1983 and is headquartered in Westbrook, US

IDEXX Laboratories Office Locations

IDEXX Laboratories has offices in Westbrook, Saint Petersburg, Sacramento, West Sacramento and in 24 other locations
Westbrook, US
Fremont, US
Houston, US
Worthington, US
Worthing, GB
Syracuse, US
Irvine, US
Greensboro, US
Rockville, US
Westminster, US
Roswell, US
Phoenix, US
Markham, CA
Ontario, US
Portland, US
New York, US
Norcross, US
Eau Claire, US
Memphis, US

IDEXX Laboratories Metrics

IDEXX Laboratories Summary

Market capitalization

$13.3 b

Closing share price

$151.5
IDEXX Laboratories's current market capitalization is $13.3 b.

IDEXX Laboratories Financials

IDEXX Laboratories's revenue is $1.4 b in FY, 2013 which is a 7.3% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$1.4 b$1.5 b$1.6 b$1.8 b

Revenue growth, %

7.9%7.8%10.8%

Gross profit

$756.1 m$816.1 m$890.3 m

EBIT

$266.8 m$260.3 m$299.9 m

Net Income

$187.8 m$182 m$192.1 m$222.1 m

Operating cash flow

$55.1 m$43.5 m($193.5 m)

IDEXX Laboratories Market Value History

IDEXX Laboratories Job Categories

IDEXX Laboratories Online Presence

IDEXX Laboratories Company Life

You may also be interested in